Publicacións nas que colabora con José María Cruz-Fernández (19)

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2011

  1. Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome

    International Journal of Cardiology, Vol. 146, Núm. 2, pp. 219-224

  2. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: The ALPHEE study

    Circulation, Vol. 124, Núm. 24, pp. 2649-2660

2010

  1. The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial

    Health and Quality of Life Outcomes, Vol. 8

2008

  1. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome

    Atherosclerosis, Vol. 201, Núm. 1, pp. 176-183

2007

  1. Diagnóstico y tratamiento del riesgo cardiometabólico

    Medicina Clinica

2006

  1. Desequilibrio entre la oferta y las necesidades de cardiólogos en España. Análisis de la situación actual, previsiones futuras y propuestas de solución

    Revista Espanola de Cardiologia, Vol. 59, Núm. 7, pp. 703-717

2005

  1. Management and outcome of patients with established coronary artery disease: The Euro Heart Survey on coronary revascularization

    European Heart Journal, Vol. 26, Núm. 12, pp. 1169-1179

2004

  1. Efecto de un programa sencillo de educación de los profesionales en el cumplimiento de medidas de prevención secundaria en el momento del alta hospitalaria tras un síndrome coronario agudo. Proyecto CAM

    Revista Espanola de Cardiologia, Vol. 57, Núm. 11, pp. 1017-1028

2003

  1. Marcadores de inflamación y estratificacin de riesgo en pacientes con síndrome coronario agudo: Diseño del estudio SIESTA (Sytemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes)

    Revista Espanola de Cardiologia, Vol. 56, Núm. 4, pp. 389-395

2000

  1. Incidence of haemorrhagic stroke in fibrinolytic treated patients after acute myocardial infarction. TIM study: A subgroup analysis

    Heart, Vol. 83, Núm. SUPPL. 2

  2. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction

    European Heart Journal, Vol. 21, Núm. 6, pp. 457-465

  3. Triflusal vs aspirin in the acute phase of myocardial infarction: The TIM study main results

    Heart, Vol. 83, Núm. SUPPL. 2

1999

  1. Incidence of vascular stroke in patients with acute myocardial infarction receiving fibrinolytic treatment

    European Heart Journal, Supplement

  2. Interaction between antiplatelet agents and ACE inhibitors in patients with acute myocardial infarction

    European Heart Journal, Supplement

1998

  1. Continuous education in cardiology. Education Commission, Spanish Society of Cardiology

    Revista española de cardiología, Vol. 51, Núm. 2